- Home
- / Leica Biosystems Nussloch
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Leica Biosystems Nussloch financials data including stock price, CreditSafe score, income statement, balance sheet, and acquistions and subsidiaries.
Revenue
$254.8 M
FY, 2022
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|
| Revenue | 161.9M | 203.0M | 254.8M |
| Cost of goods sold | 83.6M | 106.3M | 154.7M |
| Gross profit | 78.3M | 96.7M | 100.1M |
| Gross profit margin, % | 48.3% | 47.6% | 39.3% |
| General and administrative expense | 29.1M | 34.9M | 35.8M |
| Operating expense total | 55.7M | 62.6M | 71.2M |
| Depreciation and amortization | 1.5M | 2.0M | 2.2M |
| Interest income | 141.1K | 152.3K | 448.9K |
| Interest expense | 1.7M | 1.4M | 2.4M |
| Net Income | 23.9M | 43.4M | 32.6M |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |